BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically ...

Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) have addressed a long-standing challenge in the pharmaceutical industry, with the development of a two-step, one-pot method for ...

FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of its peptide-oligonucleotide conjugates. This validation resulted from combining oligonucleotides with ...

For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat ...

For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat ...

Peptide therapeutics have revolutionized the treatment of disease, but their characteristics typically restrict them to administration by injection. Now, researchers have succeeded in creating an oral ...

Cyclic peptides derived from flaxseed, commonly known as cyclolinopeptides or linusorbs, represent a unique class of naturally occurring bioactive compounds. Their cyclic structure confers enhanced ...

A discovery made by scientists at King’s College London could speed up efforts to produce new antibiotics in the fight against antimicrobial resistance. In a paper published in the Journal of the ...

Co. Ltd. has identified cyclic peptides targeting fibroblast activating protein α (FAP) reported to be useful for the treatment of cancer.

The University of California, Berkeley, has spun out Insamo, a start-up focused on making oral cyclic peptides, which would replace medicines that have so far only been available as injections or ...